Metraipolis › archive › dc_ebece4594a9c

Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance — Europe PMC PMID:42093910

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42093910
DOI
10.17179/excli2026-9258
License (as archived)
solo-consultazione
Archived
2026-11-04T08:51:26.583Z
SHA-256 of the archived text
b5a2ce8a1484059249fdb670c009807ad883ae0b80946185af32e31aa89b8e41
Stable URL of this page
https://metraipolis.com/documento/dc_ebece4594a9c

How to cite

Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance — Europe PMC PMID:42093910 — Europe PMC (en), https://europepmc.org/article/MED/42093910 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebece4594a9c (Metraipolis archive dc_ebece4594a9c, sha256 b5a2ce8a1484059249fdb670c009807ad883ae0b80946185af32e31aa89b8e41)
BibTeX
@misc{dcebece4594a9c,
  title = {Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance — Europe PMC PMID:42093910},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42093910},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebece4594a9c; sha256 b5a2ce8a1484059249fdb670c009807ad883ae0b80946185af32e31aa89b8e41},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42093910. Agents can read the archived copy with the MCP tool read_document.